Filing Details

Accession Number:
0001439222-23-000123
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-10 16:07:15
Reporting Period:
2023-08-08
Accepted Time:
2023-08-10 16:07:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1439222 Agios Pharmaceuticals Inc. AGIO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1546216 Brian Goff C/O Agios Pharmaceuticals, Inc.
88 Sidney Street
Cambridge MA 02139
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-08-08 22,691 $0.00 36,770 No 4 M Direct
Common Stock Disposition 2023-08-08 10,178 $25.48 26,592 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted stock units Disposition 2023-08-08 22,691 $0.00 22,691 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
45,382 No 4 M Direct
Footnotes
  1. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units.
  2. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
  3. The restricted stock units were granted on August 8, 2022. Beginning on August 8, 2023, the shares underlying the restricted stock units will vest in three equal annual installments.